1h Free Analyst Time
The AI in cancer diagnostics market is forecasted to grow by USD 826.7 million during 2024-2029, accelerating at a CAGR of 23.6% during the forecast period. The report on the AI in cancer diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating cancer burden and critical need for diagnostic efficiency, rapid advancements in AI algorithms and computational infrastructure, and surging investment, strategic alliances, and evolving regulatory frameworks.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The AI in cancer diagnostics market is segmented as below:
By Component
- Software
- Hardware
- Services
By Type
- Breast cancer
- Lung cancer
- Prostate cancer
- Blood cancer
- Others
By End-user
- Hospitals
- Surgical centers
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the AI in cancer diagnostics market covers the following areas:
- AI In Cancer Diagnostics Market sizing
- AI In Cancer Diagnostics Market forecast
- AI In Cancer Diagnostics Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Component
8 Market Segmentation by Type
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global AI in cancer diagnostics market: Aidoc, Concr Pty Ltd, DELFI Diagnostics Inc., F. Hoffmann La Roche Ltd., Flatiron Health, Freenome Holdings Inc., GE Healthcare Technologies Inc., GLEAMER, Google DeepMind, Ibex Medical Analytics, Koninklijke Philips NV, Microsoft Corp., Oncora Medical Inc., Paige AI Inc., PathAI Inc., Proscia Inc., Siemens Healthineers AG, and Tempus Labs Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is ascendancy of multimodal AI for holistic patient stratification."
According to the report, one of the major drivers for this market is the escalating cancer burden and critical need for diagnostic efficiency.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aidoc
- Concr Pty Ltd
- DELFI Diagnostics Inc.
- F. Hoffmann La Roche Ltd.
- Flatiron Health
- Freenome Holdings Inc.
- GE Healthcare Technologies Inc.
- GLEAMER
- Google DeepMind
- Ibex Medical Analytics
- Koninklijke Philips NV
- Microsoft Corp.
- Oncora Medical Inc.
- Paige AI Inc.
- PathAI Inc.
- Proscia Inc.
- Siemens Healthineers AG
- Tempus Labs Inc.
